UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4626
Ennis
EBF
$564M
| $2.21M | ﹤0.01% |
104,559
+85,263
| +442% | +$1.83M |
|
4627
Innovative Solutions & Support
ISSC
$361M
| $2.2M | ﹤0.01% |
258,068
+209,772
| +434% | +$1.57M |
|
4628
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$631M
| $2.2M | ﹤0.01% |
+24,484
| New | +$2.88M |
|
4629
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.74B
| $2.2M | ﹤0.01% |
22,547
+3,635
| +19% | +$341K |
|
|
FLNA
4630
Filana Therapeutics
FLNA
$48.1M
| $2.2M | ﹤0.01% |
930,726
+841,853
| +947% | +$14.8M |
|
|
XRN
4631
Chiron Real Estate Inc
XRN
$477M
| $2.2M | ﹤0.01% |
56,877
-810
| -1% | -$35.8K |
|
|
NXDR
4632
Nextdoor Holdings
NXDR
$986M
| $2.19M | ﹤0.01% |
925,466
+813,093
| +724% | +$2.02M |
|
4633
Columbia India Consumer ETF
INCO
$239M
| $2.19M | ﹤0.01% |
33,988
-2,208
| -6% | -$153K |
|
|
CON
4634
Concentra Group Holdings
CON
$4.36B
| $2.19M | ﹤0.01% |
110,680
+97,811
| +760% | +$2.02M |
|
|
HUYA
4635
Huya Inc
HUYA
$558M
| $2.19M | ﹤0.01% |
711,881
+477,773
| +204% | +$1.7M |
|
|
PLL
4636
DELISTED
Piedmont Lithium
PLL
| $2.18M | ﹤0.01% |
249,559
+230,786
| +1,229% | +$2.71M |
|
4637
Acco Brands
ACCO
$407M
| $2.18M | ﹤0.01% |
415,304
+354,042
| +578% | +$1.97M |
|
|
KREF
4638
KKR Real Estate Finance Trust
KREF
$499M
| $2.18M | ﹤0.01% |
215,609
+61,859
| +40% | +$709K |
|
4639
CALL
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $2.17M | ﹤0.01% |
41,600
+22,500
| +118% | +$1.25M |
|
4640
American Public Education
APEI
$940M
| $2.17M | ﹤0.01% |
100,637
+67,561
| +204% | +$1.21M |
|
|
OPP
4641
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$191M
| $2.17M | ﹤0.01% |
260,053
-6,202
| -2% | -$53.3K |
|
|
PONY
4642
Pony AI Inc
PONY
$3.54B
| $2.17M | ﹤0.01% |
+150,964
| New | +$2.01M |
|
|
VSXY
4643
Victoria's Secret
VSXY
$7.83B
| $2.16M | ﹤0.01% |
52,266
-39,510
| -43% | -$1.4M |
|
4644
PUT
IQVIA
IQV
$39.3B
| $2.16M | ﹤0.01% |
11,000
| – | – |
|
|
SVM
4645
Silvercorp Metals
SVM
$2.53B
| $2.16M | ﹤0.01% |
719,822
+508,443
| +241% | +$2.01M |
|
4646
Stratasys
SSYS
$774M
| $2.16M | ﹤0.01% |
242,485
+125,234
| +107% | +$1.08M |
|
|
INVX
4647
Innovex International
INVX
$1.97B
| $2.15M | ﹤0.01% |
154,111
+85,495
| +125% | +$1.28M |
|
|
PZC
4648
DELISTED
PIMCO California Municipal Income Fund III
PZC
| $2.14M | ﹤0.01% |
311,734
-21,339
| -6% | -$154K |
|
4649
LeMaitre Vascular
LMAT
$1.86B
| $2.14M | ﹤0.01% |
23,212
+16,982
| +273% | +$1.63M |
|
4650
CALL
Keurig Dr Pepper
KDP
$40.8B
| $2.14M | ﹤0.01% |
66,500
| – | – |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.